The effect of intensive glucose lowering therapy among major racial/ethnic groups in the veterans affairs diabetes trial

Metabolism: Clinical and Experimental

Volumn 64, Issue 2, 2015, Pages 218-225

  Saremi, Aramesh ^a   Schwenke, Dawn C ^a   Bahn, Gideon ^b   Ge, Ling ^b   Emanuele, Nicholas ^c   Reaven, Peter D ^a  

^a CARL T HAYDEN VA MEDICAL CENTER   (United States)

^b Veterans Affairs Cooperative Studies Program Coordinating Center   (United States)

^c HINES VA HOSPITAL   (United States)

Author keywords

CVD; Ethnicity; Intensive glycemic control; Race; Type 2 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ANCESTRY GROUP; ARTICLE; BLACK PERSON; CARDIOVASCULAR DISEASE; CAUCASIAN; DIABETES MELLITUS; ETHNIC GROUP; FOLLOW UP; GLYCEMIC CONTROL; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREND STUDY; VETERAN; AFRICAN AMERICAN; AGED; BLOOD; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC CARDIOMYOPATHIES; ETHNOLOGY; FEMALE; HYPERGLYCEMIA; MALE; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PERSONALIZED MEDICINE; PROPORTIONAL HAZARDS MODEL; PUBLIC HOSPITAL; UNITED STATES;

AFRICAN AMERICANS; AGED; CARDIOVASCULAR DISEASES; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC CARDIOMYOPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HISPANIC AMERICANS; HOSPITALS, VETERANS; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PRECISION MEDICINE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; UNITED STATES;

EID: 84920627019     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.10.010     Document Type: Article

References (40)

1. H.C. Gerstein, M.E. Miller, R.P. Byington, D.C. Goff Jr., J.T. Bigger, and J.B. Buse Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2008 2545 2559
2. A. Patel, S. MacMahon, J. Chalmers, B. Neal, L. Billot, and M. Woodward Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2008 2560 2572
3. W. Duckworth, C. Abraira, T. Moritz, D. Reda, N. Emanuele, and P.D. Reaven Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 360 2009 129 139
4. P.D. Reaven, T.E. Moritz, D.C. Schwenke, R.J. Anderson, M. Criqui, and R. Detrano Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis Diabetes 58 2009 2642 2648
5. W.C. Duckworth, C. Abraira, T.E. Moritz, S.N. Davis, N. Emanuele, and S. Goldman The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial J Diabetes Complications 25 2011 355 361
6. H.C. Gerstein, M.E. Miller, S. Genuth, F. Ismail-Beigi, J.B. Buse, and D.C. Goff Jr. Long-term effects of intensive glucose lowering on cardiovascular outcomes N Engl J Med 364 2011 818 828
7. F.M. Turnbull, C. Abraira, R.J. Anderson, R.P. Byington, J.P. Chalmers, and W.C. Duckworth Intensive glucose control and macrovascular outcomes in type 2 diabetes Diabetologia 52 2009 2288 2298
8. K.K. Ray, S.R. Seshasai, S. Wijesuriya, R. Sivakumaran, S. Nethercott, and D. Preiss Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials Lancet 373 2009 1765 1772
9. R.R. Holman, S.K. Paul, M.A. Bethel, D.R. Matthews, and H.A. Neil 10-year follow-up of intensive glucose control in type 2 diabetes N Engl J Med 359 2008 1577 1589
10. D.M. Nathan, P.A. Cleary, J.Y. Backlund, S.M. Genuth, J.M. Lachin, and T.J. Orchard Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N Engl J Med 353 2005 2643 2653
11. P. Gaede, H. Lund-Andersen, H.H. Parving, and O. Pedersen Effect of a multifactorial intervention on mortality in type 2 diabetes N Engl J Med 358 2008 580 591
12. N. Chokrungvaranon, J. Deer, and P.D. Reaven Intensive glycemic control and cardiovascular disease: are there patients who may benefit? Postgrad Med 123 2011 114 123
13. S. Del Prato, J. LaSalle, S. Matthaei, and C.J. Bailey Tailoring treatment to the individual in type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management Int J Clin Pract 64 2010 295 304
14. T. Terry, K. Raravikar, N. Chokrungvaranon, and P.D. Reaven Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT Curr Cardiol Rep 14 2011 79 88
15. P.D. Reaven, D. Thurmond, A. Domb, R. Gerkin, M.J. Budoff, and S. Goldman Comparison of frequency of coronary artery calcium in healthy Hispanic versus non-Hispanic white men by electron beam computed tomography Am J Cardiol 92 2003 1198 1200
16. P.D. Reaven, and J. Sacks Reduced coronary artery and abdominal aortic calcification in Hispanics with type 2 diabetes Diabetes Care 27 2004 1115 1120
17. A. Saremi, T.E. Moritz, R.J. Anderson, C. Abraira, W.C. Duckworth, and P.D. Reaven Rates and determinants of coronary and abdominal aortic artery calcium progression in the Veterans Affairs Diabetes Trial (VADT) Diabetes Care 33 2010 2642 2647
18. R.L. McClelland, H. Chung, R. Detrano, W. Post, and R.A. Kronmal Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA) Circulation 113 2006 30 37
19. C.V. Breton, X. Wang, W.J. Mack, K. Berhane, M. Lopez, and T.S. Islam Carotid artery intima-media thickness in college students: race/ethnicity matters Atherosclerosis 217 2011 441 446
20. B.V. Howard, E.T. Lee, L.D. Cowan, R.R. Fabsitz, W.J. Howard, and A.J. Oopik Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study Am J Epidemiol 142 1995 254 268
21. B.V. Howard, E.T. Lee, L.D. Cowan, R.B. Devereux, J.M. Galloway, and O.T. Go Rising tide of cardiovascular disease in American Indians. The Strong Heart Study Circulation 99 1999 2389 2395
22. M.E. Pavkov, M.L. Sievers, W.C. Knowler, P.H. Bennett, and R.G. Nelson An explanation for the increase in heart disease mortality rates in diabetic Pima Indians: effect of renal replacement therapy Diabetes Care 27 2004 1132 1136
23. W. Rosamond, K. Flegal, G. Friday, K. Furie, A. Go, and K. Greenlund Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 115 2007 e69 e171
24. P.D. Sorlie, E. Backlund, N.J. Johnson, and E. Rogot Mortality by Hispanic status in the United States JAMA 270 1993 2464 2468
25. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, R.J. Adams, J.D. Berry, and T.M. Brown Heart disease and stroke statistics - 2011 update: a report from the American Heart Association Circulation 123 2010 e18 e209
26. J.Z. Willey, C.J. Rodriguez, Y.P. Moon, M.C. Paik, M.R. Di Tullio, and S. Homma Coronary death and myocardial infarction among Hispanics in the Northern Manhattan Study: exploring the Hispanic paradox Ann Epidemiol 22 2012 303 309
27. M.V. Perez, T.S. Yaw, J. Myers, and V.F. Froelicher Prognostic value of the computerized ECG in Hispanics Clin Cardiol 30 2007 189 194
28. J.M. Ruiz, P. Steffen, and T.B. Smith Hispanic mortality paradox: a systematic review and meta-analysis of the longitudinal literature Am J Public Health 103 2013 e52 e60
29. J. Xu, K.D. Kochanek, S.L. Murphy, and E. Arias Mortality in the United States, 2012 NCHS Data Brief 2014 1 8
30. K.J. Hunt, R.G. Resendez, K. Williams, S.M. Haffner, M.P. Stern, and H.P. Hazuda All-cause and cardiovascular mortality among Mexican-American and non-Hispanic White older participants in the San Antonio Heart Study - evidence against the "Hispanic paradox" Am J Epidemiol 158 2003 1048 1057
31. K.J. Hunt, K. Williams, R.G. Resendez, H.P. Hazuda, S.M. Haffner, and M.P. Stern All-cause and cardiovascular mortality among diabetic participants in the San Antonio Heart Study: evidence against the "Hispanic Paradox" Diabetes Care 25 2002 1557 1563
32. I. Lerman-Garber, A.R. Villa, and E. Caballero Diabetes and cardiovascular disease. Is there a true Hispanic paradox? Rev Invest Clin 56 2004 282 296
33. C.J. Rodriguez, M. Allison, M.L. Daviglus, C.R. Isasi, C. Keller, and E.C. Leira Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association Circulation 130 2014 593 625
34. C.L. Wassel, J.S. Pankow, L.J. Rasmussen-Torvik, N. Li, K.D. Taylor, and X. Guo Associations of SNPs in ADIPOQ and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis (MESA) Obesity 19 2011 840 847
35. J.A. Johnson Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics Circulation 118 2008 1383 1393
36. T.M. Davis, R.L. Coleman, and R.R. Holman Ethnicity and long-term vascular outcomes in type 2 diabetes: a prospective observational study (UKPDS 83) Diabet Med 31 2014 200 207
37. C. Abraira, J.A. Colwell, F.Q. Nuttall, C.T. Sawin, N.J. Nagel, and J.P. Comstock Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in type II diabetes Diabetes Care 18 1995 1113 1123
38. NIH policy on reporting race and ethnicity data: National Institute of Health subjects in clinical research 2001 ed. 2001 [ http://grants.nih.gov/grants/guide/notice-files/NOT-OD-01-053.html ]
39. R.R. Wing, P. Bolin, F.L. Brancati, G.A. Bray, J.M. Clark, and M. Coday Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes N Engl J Med 369 2013 145 154
40. C. Campos Addressing cultural barriers to the successful use of insulin in Hispanics with type 2 diabetes South Med J 100 2007 812 820